Canada Life’s Phibro Animal Health PAHC Stock Holding History

Canada Life’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$899K	Hold	16,254	–	–	﹤0.01%	1383
2025 Q4	$607K	Hold	16,254	–	–	﹤0.01%	1472
2025 Q3	$636K	Hold	16,254	–	–	﹤0.01%	1555
2025 Q2	$415K	Sell	16,254 -2,224	-12%	-$48.5K	﹤0.01%	1639
2025 Q1	$395K	Hold	18,478	–	–	﹤0.01%	1650
2024 Q4	$387K	Hold	18,478	–	–	﹤0.01%	1681
2024 Q3	$416K	Hold	18,478	–	–	﹤0.01%	1716
2024 Q2	$310K	Buy	18,478 +3,007	+19%	+$48.3K	﹤0.01%	1770
2024 Q1	$200K	Hold	15,471	–	–	﹤0.01%	1831
2023 Q4	$178K	Sell	15,471 -5,188	-25%	-$58.6K	﹤0.01%	1858
2023 Q3	$263K	Sell	20,659 -8	-0%	-$113	﹤0.01%	1812
2023 Q2	$283K	Sell	20,667 -116	-0.6%	-$1.66K	﹤0.01%	1795
2023 Q1	$317K	Sell	20,783 -64	-0.3%	-$978	﹤0.01%	1797
2022 Q4	$280K	Buy	20,847 +1,435	+7%	+$19.2K	﹤0.01%	1832
2022 Q3	$258K	Sell	19,412 -1,564	-7%	-$27K	﹤0.01%	1815
2022 Q2	$402K	Buy	20,976 +4,049	+24%	+$76.7K	﹤0.01%	1717
2022 Q1	$345K	Hold	16,927	–	–	﹤0.01%	1793
2021 Q4	$344K	Hold	16,927	–	–	﹤0.01%	1783
2021 Q3	$368K	Hold	16,927	–	–	﹤0.01%	1786
2021 Q2	$488K	Sell	16,927 -1,647	-9%	-$44.5K	﹤0.01%	1747
2021 Q1	$452K	Sell	18,574 -2,060	-10%	-$46.5K	﹤0.01%	1770
2020 Q4	$400K	Sell	20,634 -1,589	-7%	-$29.2K	﹤0.01%	1804
2020 Q3	$386K	Sell	22,223 -3,571	-14%	-$76.2K	﹤0.01%	1741
2020 Q2	$676K	Sell	25,794 -2,403	-9%	-$59.7K	﹤0.01%	1595
2020 Q1	$678K	Buy	28,197 +2,762	+11%	+$67.5K	﹤0.01%	1486
2019 Q4	$627K	Buy	+25,435	New	+$590K	﹤0.01%	1649
2019 Q3	–	Sell	-26,858	Closed	-$854K	–	1926
2019 Q2	$854K	Sell	26,858 -51	-0.2%	-$1.6K	﹤0.01%	1613
2019 Q1	$887K	Buy	26,909 +1,608	+6%	+$50K	﹤0.01%	1434
2018 Q4	$749K	Buy	25,301 +12	+0%	+$453	﹤0.01%	1520
2018 Q3	$1.08M	Hold	25,289	–	–	﹤0.01%	1494
2018 Q2	$1.16M	Hold	25,289	–	–	﹤0.01%	1471
2018 Q1	$1M	Buy	25,289 +235	+0.9%	+$8.7K	﹤0.01%	1513
2017 Q4	$837K	Sell	25,054 -1,500	-6%	-$53.3K	﹤0.01%	1585
2017 Q3	$977K	Hold	26,554	–	–	﹤0.01%	1525
2017 Q2	$981K	Hold	26,554	–	–	﹤0.01%	1524
2017 Q1	$745K	Buy	26,554 +1,802	+7%	+$50.8K	﹤0.01%	1602
2016 Q4	$724K	Hold	24,752	–	–	﹤0.01%	1595
2016 Q3	$672K	Buy	24,752 +1,694	+7%	+$38.3K	﹤0.01%	1588
2016 Q2	$430K	Buy	23,058 +21,209	+1,147%	+$442K	﹤0.01%	1692
2016 Q1	$50K	Hold	1,849	–	–	﹤0.01%	2125
2015 Q4	$56K	Hold	1,849	–	–	﹤0.01%	2101
2015 Q3	$59K	Hold	1,849	–	–	﹤0.01%	2013
2015 Q2	$72K	Hold	1,849	–	–	﹤0.01%	2058
2015 Q1	$65K	Buy	+1,849	New	+$59.5K	﹤0.01%	2020

Other funds holding PAHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Canada Life's PAHC Position: Q1 2026 in Review

Canada Life held its Phibro Animal Health (PAHC) position steady in Q1 2026 at 16,254 shares worth $899K. The position accounts for ﹤0.01% of the portfolio, ranked #1383.

Canada Life first reported a position in PAHC in Q1 2015 and has held it in 44 quarters since. The position peaked at $1.16M in Q2 2018. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

Canada Life held 16,254 shares of Phibro Animal Health worth $899K as of Q1 2026.
Canada Life left its Phibro Animal Health share count unchanged in Q1 2026.
Phibro Animal Health made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1383 holding.
Canada Life first reported a position in Phibro Animal Health in Q1 2015 and has held it in 44 quarters since.
Canada Life's Phibro Animal Health position peaked at $1.16M in Q2 2018.
257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.